BDX

Business Context and Reporting Period

Company: Becton, Dickinson and Company (BD)

Filing Type: Form 10-Q (Quarterly Report)

Reporting Period: Quarter and six months ended March 31, 1999

Business Overview: BD operates primarily through two segments: Medical Supplies and Devices and Diagnostic Systems. The company reported strong revenue growth driven by recent acquisitions and international expansion, though operating margins were compressed by increased expenses related to acquisitions and a business systems upgrade.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Q2 revenues increased 18% year-over-year, driven by acquisitions (including the BOC Group medical device business) and a weakening U.S. dollar. International revenues grew 40% in the Medical segment.
• Expense Increases: Selling and administrative expenses rose to 26.7% of revenue (from 25.2%) due to acquisition-related costs and reengineering charges. R&D spending jumped 54% to $67 million, including a $15 million charge for purchased in-process R&D.
• Profitability: While gross margins improved slightly, operating margins declined from 19.6% to 16.5% due to higher operating expenses. Net income decreased slightly in Q2 ($90M vs. $92M) but increased 6% for the six-month period.
• Cash Flow: Operating cash flow dropped significantly to $125 million for the six months ended March 31, 1999, compared to $242 million in the prior year, primarily due to a $204 million increase in working capital (higher inventory and receivables).
• Debt Levels: Total debt increased to $1.4 billion (45.4% of total capital) from 34.6% a year ago to fund acquisitions.

Guidance, Outlook, and Risks

• Acquisitions: BD signed an agreement on April 27, 1999, to acquire Clontech Laboratories, Inc. for approximately $200 million in a stock-for-stock exchange, expected to close in Q3 1999.
• Capital Expenditures: Full-year 1999 capital expenditures are expected to be approximately $225 million.
• Tax Rate: Management expects a full-year reported tax rate of about 25%, influenced by a favorable tax judgment in Brazil and the mix of income across jurisdictions.
• Voluntary Retirement Program: An enhanced retirement incentive was offered to 175 employees in April 1999; related expenses will be recorded in Q3 upon acceptance.
• Year 2000 Compliance: The company estimates total Y2K costs at approximately $16 million, with $7 million incurred to date. Remediation is 85% complete for IT systems, with testing and contingency planning ongoing.
• Legal Proceedings: BD is a defendant in approximately 245 product liability lawsuits regarding natural rubber latex and 10 lawsuits regarding needle-stick injuries. Management does not expect these to have a material impact on financial results.

Investor Verification Checklist

• Acquisition Integration: Verify the financial impact and integration progress of recent acquisitions (BOC Group, Clontech) on future revenue and expense lines.
• Working Capital Trends: Monitor the sustainability of the $204 million increase in working capital and its effect on future operating cash flows.
• Debt Servicing: Assess the impact of increased debt levels ($1.4B) on interest expenses and liquidity, given the $37 million net interest expense for the six-month period.
• Y2K Contingencies: Confirm that the estimated $16 million Y2K budget remains accurate and that no material third-party claims arise from compliance failures.
• Legal Exposure: Track the status of the latex and needle-stick litigation to ensure no unexpected material liabilities emerge.